Trigger Point Injections
J9 · Effective Oct 1, 2015
6 active Medicare policies list J3301, and 22 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
J9
JH · Effective Oct 1, 2015
JH
JL · Effective Oct 1, 2015
JL
22 policies from 9 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta )Effective 12/01/2022 - 10/31/2023 | Dec 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta)Effective 01/01/2021 - 11/30/2021 | Jan 1, 2021 | Prior auth requiredInferred from policy title |
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta)Effective 03/09/2018 - 11/30/2019 | Mar 9, 2018 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta)Effective 12/01/2019 - 12/31/2020 | Dec 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Zilretta (triamcinolone acetonide extended-release inject susp)Effective 11/01/2023 - 10/31/2024 | Nov 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Zilretta (triamcinolone acetonide extended-release injectable suspension) | Nov 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Zilretta (triamcinolone acetonide extended-release injectable suspension)Effective 11/01/2024 - 10/31/2025 | Nov 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J3301 |
|---|---|---|
| Dermabrasion, Chemical Peels, and Acne Surgery | May 15, 2023 | Covered |
| Glaucoma Surgery | Mar 24, 2023 | Covered |
| Knee Arthroscopy / Osteoarthritis of the Knee | Nov 21, 2023 | Covered |
| Levator Syndrome Treatments | Sep 19, 2023 | Covered |
| Viscosupplementation | Jan 1, 2024 | Covered |
| Vitiligo | Feb 16, 2024 | Covered |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone Acetonide ER Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triamcinolone Acetonide Extended-Release Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone Acetonide ER Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triamcinolone Acetonide Extended-Release Injectable (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone Acetonide Extended Release (e.g., Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone acetonide | Apr 1, 2026 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone Acetonide Injectable Suspension (Xipere) | Feb 1, 2022 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Triamcinolone Acetonide Extended-Release (Zilretta) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3301 |
|---|---|---|
| Zilretta (triamcinolone acetonide ER) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |